Description of liver disease in a cohort of HIV/HBV coinfected patients

Journal of Clinical Virology

Volumn 47, Issue 1, 2010, Pages 13-17

  Sellier, P ^a   Schnepf, N ^a   Jarrin, I ^a   Mazeron, M C ^a   Simoneau, G ^a   Parrinello, M ^a   Evans, J ^b   Lafuente Lafuente, C ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b Immeuble SCOR   (France)

Author keywords

Cohort; HIV HBV coinfection; Liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; LAMIVUDINE;

ADULT; AFRICA; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG WITHDRAWAL; EUROPE; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER BIOPSY; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SEX DIFFERENCE; UNIVARIATE ANALYSIS; VIROLOGY; VIRUS LOAD;

ADULT; ALANINE TRANSAMINASE; ANALYSIS OF VARIANCE; ANTI-HIV AGENTS; ASPARTATE AMINOTRANSFERASES; COHORT STUDIES; DNA, VIRAL; FEMALE; HEPATITIS B; HIV; HIV INFECTIONS; HUMANS; LAMIVUDINE; MALE; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 72149129466     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2009.10.010     Document Type: Article

References (24)

1. Thio C.L., Seaberg E.C., Skolasky Jr. R., Phair J., Visscher B., Munoz A., et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 360 (2002) 1921-1926
2. Kellerman S.E., Hanson D.L., McNaghten A.D., and Fleming P.L. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. J Infect Dis 188 (2003) 571-577
3. Konopnicki D., Mocroft A., de Wit S., Antunes F., Ledergerber B., Katlama C., et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 19 (2005) 593-601
4. Sheng W.H., Chen M.Y., Hsieh S.M., Hsiao C.F., Wang J.T., Hung C.C., et al. Impact of chronic hepatitis B virus (HBV) infection on outcomes of patients infected with HIV in an area where HBV infection is hyperendemic. Clin Infect Dis 38 (2004) 1471-1477
5. Gilson R.J., Hawkins A.E., Beecham M.R., Ross E., Waite J., Briggs M., et al. Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS 11 (1997) 597-606
6. Colin J.F., Cazals-Hatem D., Loriot M.A., Martinot-Peignoux M., Pham B.N., Auperin A., et al. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology 29 (1999) 1306-1310
7. Bonacini M., Louie S., Bzowej N., and Wohl A.R. Survival in patients with HIV infection and viral hepatitis B or C: a cohort study. AIDS 18 (2004) 2039-2045
8. McMahon B.J., Holck P., Bulkow L., and Snowball M. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann Intern Med 135 (2001) 759-768
9. Amin J., Law M.G., Bartlett M., Kaldor J.M., and Dore G.J. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet 368 (2006) 938-945
10. Lacombe K., Massari V., Girard P.M., Serfaty L., Gozlan J., Pialoux G., et al. Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV. AIDS 20 (2006) 419-427
11. Sheng W.H., Hung C.C., Kao J.H., Chang S.Y., Chen M.Y., Hsieh S.M., et al. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study. Clin Infect Dis 44 (2007) 988-995
12. ter Borg F., ten Kate F.J., Cuypers H.T., Leentvaar-Kuijpers A., Oosting J., Wertheim-van Dillen P.M., et al. Relation between laboratory test results and histological hepatitis activity in individuals positive for hepatitis B surface antigen and antibodies to hepatitis B e antigen. Lancet 351 (1998) 1914-1918 (Erratum in: Lancet 1999; 354:258)
13. Iloeje U.H., Yang H.I., Su J., Jen C.L., You S.L., and Chen C.J. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 130 (2006) 678-686
14. Chen C.J., Yang H.I., Su J., Jen C.L., You S.L., Lu S.N., et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295 (2006) 65-73
15. Fonquernie L., Serfaty L., Charrois A., Wendum D., Lefebvre B., Girard P.M., et al. Significance of hepatitis C virus coinfection with persistently normal alanine aminotransferase levels in HIV-1-infected patients. HIV Med 5 (2004) 385-390
16. Gonzalez S.A., Liu R.-C., Edlin B.R., Jacobson I.M., and Talal A.H. HIV/Hepatitis C virus-coinfected patients with normal alanine aminotransferase levels. J Acquir Immune Defic Syndr 41 (2006) 582-589
17. Sanchez-Conde M., Berenguer J., Miralles P., Alvarez F., Carlos Lopez J., Cosin J., et al. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase. Clin Infect Dis 43 (2006) 640-644
18. Maida I., Soriano V., Barreiro P., Rivas P., Labarga P., and Nunez M. AIDS Res Hum Retroviruses 23 (2007) 801-804
19. Fang C.T., Chen P.J., Chen M.Y., Hung C.C., Chang S.C., Chang A.L., et al. Dynamics of plasma hepatitis B virus levels after highly active antiretroviral therapy in patients with HIV infection. J Hepatol 39 (2003) 1028-1035
20. Puoti M., Cozzi-Lepri A., Arici C., Moller N.F., Lundgren J.D., Ledergerber B., et al. Impact of lamivudine on the risk of liver-related death in 2,041 HBsAg- and HIV-positive individuals: results from an inter-cohort analysis. Antivir Ther 11 (2006) 567-574
21. Shamliyan T.A., Macdonald R., Shaukat A., Taylor B.C., Yuan J.M., Johnson J.R., et al. Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference. Ann Intern Med 150 (2009) 111-124
22. Soriano V., Puoti M., Bonacini M., Brook G., Cargnel A., Rockstroh J., et al. Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel. AIDS 19 (2005) 221-240 (Erratum in: AIDS. 2005;19:3 p following 640)
23. Proceedings of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. J Hepatol 2006;44(Supp1.):S77-94.
24. Gaglio P.J., Sterling R., Daniels E., Tedaldi E., and Terry Beirn Community Programs for Clinical Research on AIDS Hepatitis Working Group. Hepatitis B virus and HIV coinfection: results of a survey on treatment practices and recommendations for therapy. Clin Infect Dis 45 (2007) 618-623